These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2934723)

  • 1. [Does POR 8 (ornithine-vasopressin) have deleterious side effects?].
    Lamazou J; Muchada R; Roux MJ; Lucchesi G; Haro D; Palayer C
    Presse Med; 1985 Dec; 14(43):2193. PubMed ID: 2934723
    [No Abstract]   [Full Text] [Related]  

  • 2. [Severe hypertensive crisis related to the use of POR 8(ornithine vasopressin) in gynecologic surgery. 2 cases].
    Souron R; Lepage JY; Gregoire F; Wessel P; Pinaud M
    Presse Med; 1985 Apr; 14(17):982. PubMed ID: 3158942
    [No Abstract]   [Full Text] [Related]  

  • 3. [Supraventricular tachycardia following POR 8 (ornipressin)--administration in an infant].
    Abel M; Goebel A; von Gravert H
    Anaesthesist; 1987 Nov; 36(11):653-4. PubMed ID: 3425872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Better use of POR 8].
    Dargent D; Audra P; Miellet CC
    Presse Med; 1986 Jun; 15(23):1106. PubMed ID: 2942905
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of a peripheral vasoconstrictor: ornithine-8-vasopressin (POR 8) in plastic and esthetic surgery].
    Mouly R; Negre CV
    Ann Chir Plast Esthet; 1983; 28(4):390-2. PubMed ID: 6667011
    [No Abstract]   [Full Text] [Related]  

  • 6. Maximum safe dose of POR8.
    Lamont AS; Yorke P
    Anaesth Intensive Care; 1987 Nov; 15(4):467. PubMed ID: 3425888
    [No Abstract]   [Full Text] [Related]  

  • 7. [POR 8 (ornipressin). Local vasoconstrictive effect and hemodynamic activity during surgery in ENT clinics].
    Hirlinger WK; Dell U; Pirsig W; Sigg O
    Anaesthesist; 1984 Mar; 33(3):149-53. PubMed ID: 6721128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Undesirable effects following the local injection of ornipressin during general anesthesia: can the risk be lessened? A prospective study].
    Kleemann PP; Jantzen JP; Dick W
    Anaesthesist; 1988 Aug; 37(8):551-7. PubMed ID: 3177879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The adverse effects induced by ornipressin during oral and maxillofacial surgical interventions under general anesthesia].
    Chiarini L; Cantoni E; Bettelli G; Mattioli AV; Cappello C
    Minerva Stomatol; 1991; 40(1-2):77-9. PubMed ID: 2041535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of nitroglycerin on ornipressin (POR 8)-induced systemic and cardiovascular circulatory changes. An animal experimental study].
    Veit S
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1994 Apr; 29(2):108-14. PubMed ID: 8199279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local infiltration of ornithine 8-vasopressin (POR 8) as a vasoconstrictive agent in surgical pelviscopy (applied to myoma enucleation, salpingotomy in cases of tubal pregnancy and peripheral salpingostomy).
    Semm K; Mettler L
    Endoscopy; 1988 Nov; 20(6):298-304. PubMed ID: 3229389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of local vasoconstrictors during halothane anesthesia. 3. Evaluation of POR-8 (ornithine 8-vasopressin)].
    Nishioka K; Yusa T; Shima T
    Masui; 1970 Dec; 19(13):1438-43. PubMed ID: 5531036
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute pulmonary oedema following administration of ornithine-8-vasopressin.
    Borgeat A; Popovic V; Nicole A; Schwander D
    Br J Anaesth; 1990 Oct; 65(4):548-51. PubMed ID: 2248825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Value of POR 8 in the treatment of burns].
    De Mey A; Capouet V; Govaerts M
    Rev Med Brux; 1989 Apr; 10(4):160-2. PubMed ID: 2664963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pronounced bradycardia after application of POR-8 (Ornipressin) under total intravenous anesthesia with propofol.
    Marsch SC; Schaefer HG
    Acta Anaesthesiol Scand; 1990 Aug; 34(6):514. PubMed ID: 2239127
    [No Abstract]   [Full Text] [Related]  

  • 16. Intra-arterial vasopressin administration complicated by adverse cardiodynamic effects.
    Azar D; Thomford NR; Pace WG; Sirinek KR
    Rev Surg; 1977; 34(2):140-4. PubMed ID: 854701
    [No Abstract]   [Full Text] [Related]  

  • 17. [Ornipressin (POR 8)--effect on coronary blood circulation and the peripheral circulation. An animal experimental study].
    Veit S; Poethko C; Heidelmeyer CF; Brückner JB
    Anaesthesist; 1993 Sep; 42(9):597-604. PubMed ID: 8214531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The use of Ornipressin in dental local anesthesia].
    Schottke C; Mehnert J; Drauschke M
    Stomatol DDR; 1978 Sep; 28(9):644-8. PubMed ID: 282700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinico-pharmacological case (2). Bradycardia and ventricular tachycardia of the torsades de pointes type as a side effect of vasopressin: 3 case reports].
    Kupferschmidt H; Meier CH; Sulzer M; Meier PJ; Bühler H
    Praxis (Bern 1994); 1996 Mar; 85(11):340-3. PubMed ID: 8643894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacological vasoconstriction in gynecology. Results obtained with ornithine-8-vasopressin].
    Saccà V; Testori P; Valsecchi A
    Riv Ital Ginecol; 1980; 59(1):59-63. PubMed ID: 7466197
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.